CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma [Phase 3]
Summary
A Phase 3 clinical trial compares IMRT plus cisplatin versus IMRT alone in stage II nasopharyngeal carcinoma; current status is not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN